Reducing Influenza Hospitalizations in Elderly Adults: A Review
This paper examines the effectiveness of trivalent inactivated influenza vaccines in reducing hospitalizations among elderly individuals aged 65 and older. Drawing on a systematic review of meta-analyses and randomized controlled trials identified through PUBMED, EMBASE, and MEDLINE, the paper evaluates current vaccine coverage gaps, hospitalization and mortality burdens, and the methodological limitations that complicate accurate efficacy measurement. Key themes include selection bias in observational studies, age-related immune decline, and the variable protection afforded by influenza vaccines across health statuses and care settings. The paper concludes by identifying implications for clinical practice and future research, including the need for improved bias-adjustment methods, better confounder data, and biological markers that distinguish immunosenescent from healthy immune states.
- Introduction: Influenza Vaccination and Elderly Hospitalization: Overview of influenza vaccine use in adults 65+
- Background and Clinical Significance: Hospitalization burden and vaccine coverage gaps
- Search Strategy and Evidence Integration: Literature search methods and key study findings
- Critique of Evidence and Research Themes: Methodological limitations and shared study themes
- Comparative Evaluation and Feasibility of Practice Change: Bias challenges and strategies for improving practice
- Barriers to Change: Obstacles to accurate influenza mortality measurement
- Summary and Implications for Practice: Key findings and future research recommendations
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Grounds its clinical argument in specific quantitative evidence, such as the 57% versus 23% efficacy differential between the 60–69 and 70+ age groups from the Netherlands RCT, making abstract claims concrete and persuasive.
- Balances advocacy for expanded vaccination with an honest critique of methodological limitations, demonstrating critical thinking rather than uncritical acceptance of existing evidence.
- Systematically moves from evidence presentation to critique, then to practice implications — a structure that reflects rigorous academic reasoning appropriate for advanced practice nursing.
Key academic technique demonstrated
The paper exemplifies evidence synthesis with critical appraisal. Rather than simply reporting what studies found, it identifies cross-study weaknesses — particularly selection bias and inconsistent case definitions — and connects these limitations directly to why practice change is difficult. This technique of integrating and then interrogating the evidence base is central to evidence-based practice in nursing and healthcare.
Structure breakdown
The paper opens with a practice problem statement and moves through background significance, literature search methodology, evidence synthesis, critique, cross-study theme identification, comparison with practice, feasibility and barriers to change, and a concluding summary with research implications. Each section builds logically on the last, mirroring the structure of a clinical evidence review or practice improvement proposal common in graduate-level nursing coursework.
Introduction: Influenza Vaccination and Elderly Hospitalization
Immunization has been regarded as the keystone of influenza-linked mortality and morbidity prevention (Dominguez et al., 2016). The efficacy of Inactivated Influenza Vaccine in elderly individuals has been studied extensively; a majority of scholars strongly recommend immunization in individuals aged 65 and older (Dawood et al., 2014). Existing vaccines are administered for the purpose of inducing serum anti-hemagglutinin antibodies to prevent illness and infection resulting from natural influenza exposure. Administration of annual influenza shots to vulnerable persons continues to be practiced on a widespread scale, with aged persons — that is, those 65 years of age and older — as the key target population.
Trivalent inactivated vaccines for influenza are deemed to be both efficient and economical. However, despite extensive influenza inoculation drives, elderly inpatients are increasingly seen in hospitals for severe cardiovascular and respiratory issues during recent yearly national outbreaks of influenza (Lang et al., 2012).
Background and Clinical Significance
Despite the extensive availability of influenza inoculation initiatives, poor vaccination coverage rates persist; the nation's health sector fails to meet WHO targets for vaccine coverage. This, in part, accounts for influenza infection continuing as a key global public health issue. Authors of a National Institutes of Health study concluded that seasonal influenza annually accounted for approximately 41,000 deaths and over 200,000 hospitalizations, and that influenza constituted the seventh leading cause of mortality. Influenza-related mortality and morbidity is most concentrated among individuals aged 65 and older, as this group is more vulnerable to developing complications. Estimates for 2012–13 reveal that influenza immunization showed only moderate effectiveness in decreasing hospitalizations due to respiratory complications and ailments (Fry et al., 2014). Researchers have also found that elderly persons — particularly those diagnosed with immunological disorders or chronic ailments — accounted for nine out of ten deaths linked to influenza. Significant uncertainties nonetheless remain regarding the influenza-linked hospitalization burden in aged persons (Goldstein et al., 2015).
The common belief is that existing influenza vaccines prove effective in preventing hospitalizations among elderly individuals aged 65 and older. Although trivalent inactivated influenza vaccines avert laboratory-confirmed influenza among roughly 70 to 90% of healthy adults in cases where the circulating virus and vaccine are antigenically identical, only a vague picture emerges in the case of elderly persons. This greatly restricts the effectiveness of randomized clinical trials (RCTs) in informing clinicians of the benefits of inoculation for avoiding hospitalization.
A Netherlands-based placebo-controlled RCT performed during the 1991–92 flu season is considered the largest and best-designed study in this regard. A total of 1,838 healthy volunteers aged 60 years or older received either the trivalent inactivated influenza vaccine or a placebo at random. Following age-wise stratification, the research team estimated 57% influenza vaccination success in participants aged 60 to 69 years; however, the vaccine was successful in only 23% of participants in the 70-and-older age group. This finding indicates that vaccine efficacy diminishes further with age, which in part reflects age-related changes in immune function (Lang et al., 2012).
Existing influenza vaccine efficacy estimates are therefore chiefly gleaned from observational research, often employing research databases or healthcare service utilization data. Drawing on meta-analyses that summarize such estimates, this study examines the efficiency of current influenza vaccine programs in reducing future hospitalization risks among elderly individuals (65 years and older) compared to non-vaccinated individuals. It also considers present and future strategies for optimizing influenza vaccine efficacy in this high-risk group.
Search Strategy and Evidence Integration
To identify all meta-analyses assessing influenza vaccine efficacy among aging and elderly populations, an electronic literature search of databases was conducted through Ovid Technologies (PUBMED, EMBASE, MEDLINE) using the following keyword combinations: "influenza vaccine" [MeSH] OR "vaccine" AND "influenza" [All Fields]. Relevant publications were selected based on study title, abstract, and body. The search was limited to trivalent inactivated influenza vaccines, and only RCTs with clinical endpoints (efficacy versus no intervention or placebo) were considered (Lang et al., 2012).
A Spain-based study by Dominguez and colleagues, which evaluated 1,038 vaccinated and unvaccinated individuals, found low inoculation rates in the country and recommended increasing immunization to prevent hospitalizations among elderly individuals (2016). Matias and colleagues examined data from British national databases, focusing on influenza-linked hospitalizations and mortality from 1997 to 2009 (2016). Study authors recorded the highest hospitalization and mortality rates in the over-75 age group — 131 deaths and 252 hospitalizations per 100,000 individuals. A further review of vaccine efficacy among elderly persons aged 65 and older examined 64 studies in total, including randomized, cohort, case-control, and quasi-randomized designs evaluating efficacy against laboratory-confirmed cases of influenza or clinically similar ailments. Influenza vaccine efficacy against similar diseases was found to be 23%, while it was deemed non-significant for laboratory-confirmed influenza (Lang et al., 2012).
Among highly vulnerable elderly individuals with comorbid ailments, vaccination proved to be 49% effective in preventing hospital admission and 29% effective in preventing mortality. Therefore, when influenza vaccine efficacy in adult subjects is stratified by health status and age, a different picture emerges for elderly persons. In fact, in a majority of observational studies, adjustments for underlying illness led to further increases in influenza vaccine efficacy estimates (Lang et al., 2012).
References
Darvishian, M., Gefenaite, G., Turner, R. M., Pechlivanoglou, P., Van der Hoek, W., Van den Heuvel, E. R., & Hak, E. (2014). After adjusting for bias in meta-analysis seasonal influenza vaccine remains effective in community-dwelling elderly. Journal of Clinical Epidemiology, 67(7), 734–744.
Dawood, F. S., Prapasiri, P., Areerat, P., Ruayajin, A., Chittaganpitch, M., Muangchana, C., … & Olsen, S. J. (2014). Effectiveness of the 2010 and 2011 Southern Hemisphere trivalent inactivated influenza vaccines against hospitalization with influenza-associated acute respiratory infection among Thai adults aged ≥ 50 years. Influenza and Other Respiratory Viruses, 8(4), 463–468.
Dominguez, A., Soldevila, N., Toledo, D., Godoy, P., Castilla, J., Force, L., … & Martin, V. (2016). Factors associated with influenza vaccination of hospitalized elderly patients in Spain. PLOS ONE, 11(1), e0147931.
Fry, A. M., Kim, I. K., Reed, C., Thompson, M., Chaves, S. S., Finelli, L., & Bresee, J. (2014). Modeling the effect of different vaccine effectiveness estimates on the number of vaccine-prevented influenza-associated hospitalizations in older adults. Clinical Infectious Diseases, 59(3), 406–409.
Goldstein, E., Greene, S. K., Olson, D. R., Hanage, W. P., & Lipsitch, M. (2015). Estimating the hospitalization burden associated with influenza and respiratory syncytial virus in New York City, 2003–2011. Influenza and Other Respiratory Viruses, 9(5), 225–233.
Lang, P. O., Mendes, A., Socquet, J., Assir, N., Govind, S., & Aspinall, R. (2012). Effectiveness of influenza vaccine in aging and older adults: Comprehensive analysis of the evidence.
Matias, G., Taylor, R. J., Haguinet, F., Schuck-Paim, C., Lustig, R. L., & Fleming, D. M. (2016). Modelling estimates of age-specific influenza-related hospitalization and mortality in the United Kingdom. BMC Public Health, 16(1), 1.
Create your account
Always verify citation format against your institution’s current style guide requirements.